Pfizer/BioNTech request full FDA approval of COVID-19 booster vaccine

Pfizer/BioNTech request full FDA approval of COVID-19 booster vaccine

Pfizer/BioNTech have initiated an application for full FDA approval of its COVID-19 vaccine booster shot for individuals aged 16 and up, the companies announced Wednesday, noting an expected completion by the end of the week.